Aligos Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In South San Franciscocaliforniafounded In 2018The Company Focuses On Developing Innovative Treatments For Liver And Viral Diseasesaiming To Address Unmet Medical Needs In These Areastheir Mission Is To Improve Patient Outcomes Through A Science Driven Approachutilizing Expertise In Medicinal Chemistry And Biology The Company S Pipeline Features Several Promising Compoundsincluding Alg 000184 For Chronic Hepatitis Balg 055009 For Metabolic Dysfunction Associated Steatohepatitisalg 125755 Also Targeting Chronic Hepatitis Band Alg 097558 Aimed At Covid 19Aligos Therapeutics Collaborates With Notable Partners Such As Merck And Emory University To Advance Its Research And Development Effortsthe Company Operates In Multiple Regionsincluding The United Statesbelgiumchinaand Australiaand Is Publicly Listed On Nasdaq Under The Ticker Symbol Algs
